Temporal Arteritis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-06-12
Clinical Trial Update: Ustekinumab for the Treatment of Giant Cell Arteritis [Phase 1, Phase 2]
Phase 1/2 trial of ustekinumab for Giant Cell Arteritis was terminated, with results posted in 2020.